Squarepoint Ops LLC Denali Therapeutics Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 33,723 shares of DNLI stock, worth $805,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,723

Previous 123,680 72.73%

Holding current value

$805,642

Previous $2.87 Million 65.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.96 - $31.05 $1.89 Million - $2.79 Million	-89,957 Reduced 72.73%	33,723 $982,000
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $879,737 - $1.37 Million	58,806 Added 90.65%	123,680 $2.87 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $800,285 - $1.18 Million	50,555 Added 353.06%	64,874 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $231,967 - $331,914	14,319 New	14,319 $307,000
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $5.16 Million - $7.7 Million	235,662 New	235,662 $5.43 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $347,089 - $514,953	13,365 New	13,365 $410,000
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $719,002 - $1.21 Million	-34,435 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $998,615 - $1.63 Million	34,435 New	34,435 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $732,548 - $946,344	-17,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $55,752 - $89,964	-1,150 Reduced 6.27%	17,200 $868,000
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $655,006 - $1.02 Million	13,022 Added 244.41%	18,350 $1.44 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $286,646 - $434,391	5,328 New	5,328 $304,000
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $531,621 - $1.35 Million	-14,411 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $333,326 - $559,723	14,411 New	14,411 $516,000
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $268,660 - $372,953	-18,657 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $188,114 - $269,155	-12,279 Reduced 39.69%	18,657 $286,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $28.14 $1.37 Million - $2.09 Million	-74,204 Reduced 70.58%	30,936 $642,000
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $1.89 Million - $2.59 Million	105,140 New	105,140 $2.44 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.21B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Denali Therapeutics Inc. Transaction History